Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038634 · ClinicalTrials.gov registry record · Phase 4
Ultrasound-guided Injection for DeQuervain's
A Phase 4 study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT02038634 is a Phase 4 study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 16 participants.
The verdict
NCT02038634, a Phase 4 study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
The investigators aim to perform a prospective study to evaluate the effectiveness of blind corticosteroid injections to US-guided injections for the treatment of de Quervain's disease. The results of the study will be used to validate current injection protocols or support the incorporation of ultrasonography to treat the disease.
Interventions
- DEVICE Ultrasound
- DRUG Betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-08-05 |
| Est. Completion | 2021-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02038634
The ClinicalTrials.gov registry entry for NCT02038634 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT02038634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02038634 about?
NCT02038634 is a clinical study titled "Ultrasound-guided Injection for DeQuervain's". The investigators aim to perform a prospective study to evaluate the effectiveness of blind corticosteroid injections to US-guided injections for the treatment of de Quervain's disease. The results of the study will be used to validate current injection protocols or support the incorporation of ultr...
What is the current status of trial NCT02038634?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2014-08-05. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT02038634?
The interventions under investigation include: Ultrasound (DEVICE), Betamethasone (DRUG).
Who is sponsoring clinical trial NCT02038634?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.